Glyxambi film-coated tablets
Sponsors
Humanis Saglık Anonim Sirketi
Conditions
Type 2 Diabetes Mellitus (T2DM)
Phase 1
Bioequivalence Study to Compare Empagliflozin + Linagliptin 25 mg/5 mg Film-coated Tablets Versus Glyxambi 25 mg/ 5 mg Film-coated Tablets
CompletedNCT06932159
Start: 2024-12-23End: 2025-04-08Updated: 2025-04-17
To Compare and Evaluate the Oral Bioavailability of Empagliflozin + Linagliptin 10 mg/5 mg Filmcoated Tablets With That of Glyxambi 10 mg/ 5 mg Film-coated Tablets in Healthy, Adult, Human Subjects Under Fasting Conditions.
CompletedNCT07039890
Start: 2025-03-08End: 2025-06-05Updated: 2025-06-26